The physiology and clinical utility of anti-Mü llerian hormone in women, Hum Reprod Update, vol.20, pp.370-85, 2014. ,
The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mü llerian hormone and response to controlled ovarian stimulation, Fertil Steril, vol.94, pp.1775-81, 2010. ,
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria, Hum Reprod, vol.26, pp.1616-1640, 2011. ,
The ISMAAR proposal on terminology for ovarian stimulation for IVF, Hum Reprod, vol.22, pp.2801-2805, 2007. ,
Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age, Fertil Steril, vol.81, pp.1002-1008, 2004. ,
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial, Lancet, vol.369, pp.743-752, 2007. ,
Milder is better? Advantages and disadvantages of ''mild'' ovarian stimulation for human in vitro fertilization, Reprod Biol Endocrinol, vol.16, pp.9-25, 2011. ,
IVF stimulation: protocols for poor responders, Methods Mol Biol, vol.1154, pp.329-370, 2014. ,
Management of poor responders in IVF: is there anything new?, Biomed Res Int, p.352098, 2014. ,
GnRH agonists vs antagonists, Best Pract Res Clin Obstet Gynaecol, vol.21, pp.57-65, 2007. ,
Long gonadotropinreleasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial, Fertil Steril, vol.101, pp.147-53, 2014. ,
FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level?, Reprod Biomed Online, vol.11, pp.555-61, 2005. ,
Defining poor ovarian response during IVF cycles, in women aged < 40 years, and its relationship with treatment outcome, Hum Reprod, vol.19, pp.1544-1551, 2004. ,
What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?, Fertil Steril, vol.94, pp.662-667, 2010. ,
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial, Hum Reprod, vol.20, pp.611-616, 2005. ,
Could mild/minimal ovarian stimulation-IVF displace conventional IVF in poor responder women undergoing IVF/ICSI treatment cycles: systematic review and meta-analysis, Proceedings of the 28th ESHRE Annual Meeting, vol.27, pp.302-339, 2012. ,
GnRHa flare and IVF pregnancy rates, Int J Gynaecol Obstet, vol.85, issue.1, pp.36-45, 2004. ,
450 IU versus 600 IU of gonadotropins in poor responders undergoing in vitro fertilization (IVF): preliminary report of a randomized controlled trial, Proceedings of the ASRM 68th Annual Meeting, vol.98, p.77, 2012. ,
Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?, Gynecol Endocrinol, vol.31, pp.79-82, 2015. ,
Mild'' vs ''long'' protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial, J Assist Reprod Genet, vol.31, pp.809-824, 2014. ,
Comparison of mild ovarian stimulation with conventional ovarian stimulation in poor responders, Clin Exp Reprod Med, vol.38, pp.159-63, 2011. ,
Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis, Gynecol Obstet Invest, vol.76, pp.233-273, 2013. ,
Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria, Hum Reprod, vol.27, pp.3481-3487, 2012. ,
Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee, Hum Fertil (Camb), vol.16, pp.144-50, 2013. ,
Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis, Gynecol Endocrinol, vol.29, pp.278-84, 2013. ,
Recombinant human follicle stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis, Reprod Biol Endocrinol, vol.12, p.17, 2014. ,
DOI : 10.1186/1477-7827-12-17
URL : https://rbej.biomedcentral.com/track/pdf/10.1186/1477-7827-12-17
The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis, Hum Reprod Update, vol.18, pp.127-172, 2012. ,
Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study, Reprod Biomed Online, vol.30, pp.191-197, 2015. ,
Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria, PLoS One, vol.9, p.99858, 2014. ,
Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study, Hum Reprod, vol.21, pp.1204-1215, 2006. ,
Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection, JAMA, vol.313, pp.255-63, 2015. ,
The journey from the old to the new AMH assay: how to avoid getting lost in the values, Reprod Biomed Online, vol.23, pp.411-431, 2011. ,